GlobalData Reports that Venture Capital Deals in radiopharmaceutical companies have grown 550% to $408m in 2023
GlobalData reports that venture capital deals in radiopharmaceuticals have grown by 550% this year totalling $408m. It was only back in 2017 when the level of financing from venture capital in the field was only $63m. It is becoming increasingly clear that radiotherapeutics represents a further exciting modality to help with the battle against cancer.
